To further explore the role of PDGFRβ signaling in activating EMT and promoting tumor initiation and progression [40, 44, 45], we performed a microarray analysis of mammary tumors from p18−/− and p18−/−;Brca1+/− mutant mice. This evidence concerns the gene CDKN2C and neoplasm.